Creades AB - CRED-A.ST

CRED-A.ST Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CRED-A.ST	1.1	12.1	10.6	8.6	0.4	24.0	-26.3	69.4	323.4	505.3
S&P 500	0.5	2.1	1.3	5.3	12.7	25.7	38.7	85.7	197.4	34547.3

Compare CRED-A.ST with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CRED-A.ST
name	Creades AB
price	79.6
changes percentage	1.1436
change	0.9
day low	79
day high	80.2
year high	84.75
year low	64.8
market cap	10689968127
price avg 50	71.775
price avg 200	73.331
exchange	STO
volume	49362
avg volume	122027
open	79
previous close	78.7
eps	8.85
pe	8.99
earnings announcement	2025-01-23T10:59:00.000+0000
shares outstanding	134296082
timestamp	2025-01-24 09:29:38

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 43.0%

Overall Quarterly Financial Health: 40.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	538000000	-4187000000	112.85
gross profit	182000000	-4187000000	104.35
gross profit ratio	0.34	1	-66.17
research and development expenses	0	-2.43	100.00
operating expenses	13000000	-239000000	105.44
interest income	36000000	13000000	176.92
interest expense	0	0	NaN
ebitda	524000000	-3959000000	113.24
ebitdaratio	0.97	0.94	3.35
operating income	522000000	-3948000000	113.22
operating income ratio	0.97	0.94	2.90
net income	558000000	-3948000000	114.13
net income ratio	1.04	0.94	10.00
eps	4.11	-29.08	114.13

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	177000000	833000000	-78.75
gross profit	177000000	1434000000	-87.66
gross profit ratio	1	1.72	-41.91
research and development expenses	0	0	NaN
operating expenses	177000000	66000000	168.18
interest income	4000000	4000000	0.00
interest expense	0	0	NaN
ebitda	178000000	767250000	-76.80
ebitdaratio	1.01	0.92	9.18
operating income	178000000	767000000	-76.79
operating income ratio	1.01	0.92	9.22
net income	182000000	771000000	-76.39
net income ratio	1.03	0.93	11.09
eps	1.34	5.68	-76.41

Overall Score of Quarterly Income Statement

0.14 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 177 million in 2024Q3 from 833 million in 2024Q2 representing a change of -78.75%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 177 million in 2024Q3 from 1,434 million in 2024Q2 representing a change of -87.66%. This indicates a sales profitability decline, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 178 million in 2024Q3 from 767 million in 2024Q2 representing a change of -76.8%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 178 million in 2024Q3 from 767 million in 2024Q2 representing a change of -76.79%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 182 million in 2024Q3 from 771 million in 2024Q2 representing a change of -76.39%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.34 in 2024Q3 from 1.34 in 2024Q2 representing a change of -76.41%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 177 million in 2024Q3 from 66 million in 2024Q2 representing a change of 168.18%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	9322000000	9053000000	2.97
total liabilities	147000000	3000000	4800.00
total equity	9175000000	8197000000	11.93
cash and cash equivalents	299000000	613000000	-51.22
short term investments	0	0	NaN
long term investments	8839000000	8328000000	6.14
total current assets	317000000	720000000	-55.97
total non current assets	9005000000	8332000000	8.08
total current liabilities	0	111000000	-100.00
total non current liabilities	147000000	3000000	4800.00
common stock	1000000	1000000	0.00
retained earnings	5531000000	5163000000	7.13
total debt	2000000	3000000	-33.33

Overall Score of Annual Balance Sheet

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 9,322 million in 2023 from 9,053 million in 2022 representing a change of 2.97%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 9,175 million in 2023 from 8,197 million in 2022 representing a change of 11.93%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 0 million in 2023 from 111 million in 2022 representing a change of -100.0%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 5,531 million in 2023 from 5,163 million in 2022 representing a change of 7.13%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2 million in 2023 from 3 million in 2022 representing a change of -33.33%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 147 million in 2023 from 3 million in 2022 representing a change of 4800.0%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 299 million in 2023 from 613 million in 2022 representing a change of -51.22%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 317 million in 2023 from 720 million in 2022 representing a change of -55.97%. This indicates a worsen liquidity position.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	10027000000	9910000000	1.18
total liabilities	155000000	220000000	-29.55
total equity	9872000000	9690000000	1.88
cash and cash equivalents	687000000	246000000	179.27
short term investments	0	0	NaN
long term investments	9326000000	9641000000	-3.27
total current assets	0	257000000	-100.00
total non current assets	0	9653000000	-100.00
total current liabilities	0	211000000	-100.00
total non current liabilities	0	9000000	-100.00
common stock	0	9690000000	-100.00
retained earnings	0	0	NaN
total debt	2000000	9000000	-77.78

Overall Score of Quarterly Balance Sheet

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 10,027 million in 2024Q3 from 9,910 million in 2024Q2 representing a change of 1.18%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 155 million in 2024Q3 from 220 million in 2024Q2 representing a change of -29.55%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 9,872 million in 2024Q3 from 9,690 million in 2024Q2 representing a change of 1.88%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 687 million in 2024Q3 from 246 million in 2024Q2 representing a change of 179.27%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 0 million in 2024Q3 from 211 million in 2024Q2 representing a change of -100.0%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 2 million in 2024Q3 from 9 million in 2024Q2 representing a change of -77.78%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Current Assets: Total Current Assets decreased to 0 million in 2024Q3 from 257 million in 2024Q2 representing a change of -100.0%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 0 in 2024Q3 from 9,690 in 2024Q2 representing a change of -100.0%. This indicates a decrease in ownership interest.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-314000000	146000000	-315.07
operating cash flow	205000000	25000000	720.00
free cash flow	205000000	25000000	720.00
capital expenditure	0	0	NaN
depreciation and amortization	2000000	2000000	0.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	-329000000	311000000	-205.79
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-190000000	-190000000	0.00
net cash used provided by financing activities	-190000000	-190000000	0.00
cash at end of period	299000000	613000000	-51.22
accounts receivables	0	0	NaN
cash at beginning of period	613000000	467000000	31.26

Overall Score of Annual Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -314 million in 2023 from 146 million in 2022 representing a change of -315.07%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 205 million in 2023 from 25 million in 2022 representing a change of 720.0%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 205 million in 2023 from 25 million in 2022 representing a change of 720.0%. This indicates an increase in cash generated after accounting for capital expenditures.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	7000000	176000000	-96.02
free cash flow	7000000	176000000	-96.02
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	489000000	-67000000	829.85
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-54000000	-54000000	0.00
net cash used provided by financing activities	-54000000	-54000000	0.00
net change in cash	441000000	55000000	701.82
cash at end of period	687000000	246000000	179.27
cash at beginning of period	246000000	191000000	28.80

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 441 million in 2024Q3 from 55 million in 2024Q2 representing a change of 701.82%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 7 million in 2024Q3 from 176 million in 2024Q2 representing a change of -96.02%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 7 million in 2024Q3 from 176 million in 2024Q2 representing a change of -96.02%. This indicates a decrease in cash generated after accounting for capital expenditures.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	3.96	-30.84	112.85
net income per share	4.11	-29.08	114.13
operating cash flow per share	1.51	0.18	720.00
free cash flow per share	1.51	0.18	720.00
cash per share	2.2	4.52	-51.22
book value per share	67.58	66.66	1.38
tangible book value per share	67.58	71.96	-6.09
shareholders equity per share	67.58	64.87	4.18
interest debt per share	0.01	0.02	-33.33
market cap	9530519848.2	10589466498	-10.00
enterprise value	9233519848.2	9979466498	-7.47
pe ratio	17.08	-2.68	736.77
price to sales ratio	17.71	-2.53	800.43
pocfratio	46.49	423.58	-89.02
pfcf ratio	46.49	423.58	-89.02
pb ratio	1.04	1.2	-13.61
ptb ratio	1.04	1.2	-13.61
ev to sales	17.16	-2.38	820.08
enterprise value over ebitda	17.62	-2.52	799.06
ev to operating cash flow	45.04	399.18	-88.72
ev to free cash flow	45.04	399.18	-88.72
earnings yield	0.06	-0.37	115.70
free cash flow yield	0.02	0.0	811.11
debt to equity	0.0	0.0	-36.01
debt to assets	0.0	0.0	-35.26
net debt to ebitda	-0.57	0.15	-467.86
current ratio	0	6.49	-100.00
interest coverage	0	0	NaN
income quality	0.37	-0.01	5920.82
dividend yield	0.02	0.02	11.11
payout ratio	0.34	-0.05	807.53
sales general and administrative to revenue	0.02	-0.0	813.40
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0	-0.08	100.00
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	79.06	206.02	-61.63
roic	0.06	-0.44	112.64
return on tangible assets	0.06	-0.4	114.82
graham net net	1.12	4.49	-75.08
working capital	317000000	609000000	-47.95
tangible asset value	9175000000	9770000000	-6.09
net current asset value	170000000	717000000	-76.29
invested capital	319000000	-107000000	398.13
average receivables	0	2500000	-100.00
average payables	0	0	NaN
average inventory	0	236000000	-100.00
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.06	-0.45	113.57
capex per share	0	0	NaN

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 17.08 on 2023-12-31 from -2.68 on 2022-12-31, representing a change of 736.77%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2023-12-31 from 0.00 on 2022-12-31, representing a change of -36.01%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio decreased to 0.00 on 2023-12-31 from 6.49 on 2022-12-31, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
CRED-A.ST
calendar year	2024	2024	NaN
revenue per share	1.3	6.14	-78.75
net income per share	1.34	5.68	-76.39
operating cash flow per share	0.05	1.3	-96.02
free cash flow per share	0.05	1.3	-96.02
cash per share	5.06	1.81	179.27
book value per share	72.72	71.37	1.88
tangible book value per share	72.72	71.37	1.88
shareholders equity per share	72.72	71.37	1.88
interest debt per share	0.01	0.07	-77.78
market cap	11288642811.65	10399400299.6	8.55
enterprise value	10603642811.65	10162400299.6	4.34
pe ratio	15.51	3.37	359.85
price to sales ratio	63.78	12.48	410.86
pocfratio	1612.66	59.09	2629.28
pfcf ratio	1612.66	59.09	2629.28
pb ratio	1.14	1.07	6.55
ptb ratio	1.14	1.07	6.55
ev to sales	59.91	12.2	391.06
enterprise value over ebitda	59.57	13.25	349.75
ev to operating cash flow	1514.81	57.74	2523.45
ev to free cash flow	1514.81	57.74	2523.45
earnings yield	0.02	0.07	-78.25
free cash flow yield	0.0	0.02	-96.34
debt to equity	0.0	0.0	-78.19
debt to assets	0.0	0.0	-78.04
net debt to ebitda	-3.85	-0.31	-1145.83
current ratio	0	1.22	-100.00
interest coverage	0	0	NaN
income quality	0.04	0.23	-82.77
dividend yield	0.0	0.01	-7.88
payout ratio	0.3	0.07	323.63
sales general and administrative to revenue	-0.03	0.08	-135.12
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	46.83	95.5	-50.96
roic	0	0.08	-100.00
return on tangible assets	0.02	0.08	-76.67
graham net net	3.92	0.19	1946.15
working capital	0	46000000	-100.00
tangible asset value	9872000000	9690000000	1.88
net current asset value	-155000000	37000000	-518.92
invested capital	11000000	58000000	-81.03
average receivables	0	84500000	-100.00
average payables	0	0	NaN
average inventory	0	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	0	NaN
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0	NaN
inventory turnover	0	0	NaN
roe	0.02	0.08	-76.83
capex per share	0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.08 on 2024-06-30 Q2, representing a change of -76.83%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.00 on 2024-09-30 Q3 from 1.22 on 2024-06-30 Q2, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 15.51 on 2024-09-30 Q3 from 3.37 on 2024-06-30 Q2, representing a change of 359.85%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-30 Q3 from 0.00 on 2024-06-30 Q2, representing a change of -78.19%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 3.47 which is lower than current price 79.6, indicates the company may be overvalued.